Senate marks Rare Disease Day to spotlight 30M Americans with forgotten illnesses
S.Res. 620 — A resolution designating February 28, 2026, as "Rare Disease Day". · Filed by John Barrasso (R-WY) · 5 cosponsors · Introduced Feb 26, 2026 · Passed chamber
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This resolution designates February 28, 2026, as 'Rare Disease Day' in the United States, recognizing the 30+ million Americans living with rare diseases and the challenges they face in obtaining diagnoses and treatments. The resolution acknowledges the Orphan Drug Act's 43-year legacy and calls for continued support of research, awareness, and regulatory innovation to develop treatments for the 95% of rare diseases still lacking FDA-approved therapies.
Why we flagged it
This is a straightforward Senate resolution designating a single day for public awareness and recognition of rare diseases. It contains no legislative mechanism, appropriations, or regulatory change—only a symbolic designation and a call to recognize the importance of rare disease research and treatment.
What the text implies
- The resolution's emphasis on the Orphan Drug Act and FDA approval rates may indirectly signal support for continued or expanded orphan drug incentives, though no specific legislative action is proposed here.
- By highlighting that 95% of rare diseases lack FDA-approved treatments, the resolution creates a rhetorical foundation for future legislative proposals to accelerate rare-disease drug development or expand incentives.
Who stands to gain
pharmaceutical companies developing orphan drugs; biotech firms focused on rare disease treatments